1. Home
  2. ACRV vs LVO Comparison

ACRV vs LVO Comparison

Compare ACRV & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • LVO
  • Stock Information
  • Founded
  • ACRV 2018
  • LVO 2009
  • Country
  • ACRV United States
  • LVO United States
  • Employees
  • ACRV N/A
  • LVO N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • LVO Restaurants
  • Sector
  • ACRV Health Care
  • LVO Consumer Discretionary
  • Exchange
  • ACRV Nasdaq
  • LVO Nasdaq
  • Market Cap
  • ACRV 59.9M
  • LVO 61.3M
  • IPO Year
  • ACRV 2022
  • LVO N/A
  • Fundamental
  • Price
  • ACRV $1.16
  • LVO $0.72
  • Analyst Decision
  • ACRV Strong Buy
  • LVO Strong Buy
  • Analyst Count
  • ACRV 5
  • LVO 1
  • Target Price
  • ACRV $19.75
  • LVO $1.50
  • AVG Volume (30 Days)
  • ACRV 1.3M
  • LVO 389.9K
  • Earning Date
  • ACRV 05-20-2025
  • LVO 05-29-2025
  • Dividend Yield
  • ACRV N/A
  • LVO N/A
  • EPS Growth
  • ACRV N/A
  • LVO N/A
  • EPS
  • ACRV N/A
  • LVO N/A
  • Revenue
  • ACRV N/A
  • LVO $126,016,000.00
  • Revenue This Year
  • ACRV N/A
  • LVO $0.69
  • Revenue Next Year
  • ACRV N/A
  • LVO N/A
  • P/E Ratio
  • ACRV N/A
  • LVO N/A
  • Revenue Growth
  • ACRV N/A
  • LVO 11.43
  • 52 Week Low
  • ACRV $1.30
  • LVO $0.55
  • 52 Week High
  • ACRV $10.29
  • LVO $1.98
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 28.93
  • LVO 51.51
  • Support Level
  • ACRV $1.32
  • LVO $0.67
  • Resistance Level
  • ACRV $1.50
  • LVO $0.76
  • Average True Range (ATR)
  • ACRV 0.17
  • LVO 0.09
  • MACD
  • ACRV 0.06
  • LVO 0.01
  • Stochastic Oscillator
  • ACRV 1.55
  • LVO 33.15

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

Share on Social Networks: